Abortion pills as an alternative to surgical abortion
Use of abortion pills
Medical abortion as a method of termination of pregnancy has long since been used in some European countries. In Croatia, medical abortion has been available since 2015, although hospitals have until recently obtained such medicines by means of interventional importation. Only recently has the Croatian Agency for Medicinal Products and Medical Devices (HALMED) approved the key combination of medicines used in medical abortion. Their administration is only possible in hospitals licensedto perform abortions,under the supervision of a doctor or healthcare professional.
The combination of medicines includes Mispregnol (misoprostol) and Mifegyne (mifepristone). Mifegyne tablets contain mifepristone, a drug that blocks the function of progesterone, a hormone that is essential for the normal development of pregnancy.
Medical abortion procedure
Patients, whose pregnancy is determined following a gynaecological examination, can be given the aborion pill. The aforementioned pill causes uterine contractions, followed by period-like pain and bleeding. After this, an ultrasound is performed to confirm that the procedure has been successful. In many European countries, this method of intentional abortion is permitted until the 9thweek of pregnancy
In comparison with the surgical method, medical abortion provides a safer and less stressful procedure for women. In addition, there are no complications such as uterine rupture, which can lead to a total removal of the uterus. When using abortion pills, the possibility of infection is reduced to a minimum, and the additional advantage of the procedure is its cost, which is twice as lower as that of the surgical abortion. On the other hand, although abortion pills represent a reliable method with fewer complications in comparison with surgical abortion, the procedure includes a disadvantage in terms of duration: medical abortion, along with side effects, may last up to several days.
Medical abortion is a better solution if it represents a less traumatic method for the woman’s body and health. The positive side of such medicines is the additional possibility of a non-invasive method oftermination of pregnancy, which is provided to women as a choice.
Ana Bolonja, MSc/ Senior Pharmacovigilance Associate
Lašćinska cesta 40
Planinska ulica 13/2
Office: +385 1 5588 297
Pharmacovigilance: +385 1 5588 297
Clinical trials: +385 1 5614 330
Registration: +385 1 242 0873
Marketing: +385 1 2420 890
Fax: +385 1 2420 860
Tel: +385 1 5588 297
Full company name
Short company name
Marti Farm Ltd. Trade and Services
Marti Farm Ltd.
Lašćinska cesta 40, HR-10000 Zagreb
Planinska ulica 13/2, HR-10000 Zagreb
a limited liability company
Commercial Court of Zagreb
HRK 20,000.00 (paid in its entirety)
Martina Diminić Smetiško, director of the
company (Representing the company
individually and independently, Responsible
person for data protection)
HR3623600001102197724 (Zagrebačka banka)
HR4324020061100628669 (Erste banka)
Full company name: Marti Farm Ltd. Trade and Services
Short company name: Marti Farm Ltd.
Headquarters: Lašćinska cesta 40, HR-10000 Zagreb
Office: Planinska ulica 13/2, HR-10000 Zagreb
Legal form: a limited liability company
Court register: Commercial Court of Zagreb
Registration number: 080751121
Share capital: HRK 20,000.00 (paid in its entirety)
Authorized representative: Martina Diminić Smetiško, director of the company (Representing the company individually and independently, Responsible person for data protection)
Bank account: HR3623600001102197724 (Zagrebačka banka), HR4324020061100628669 (Erste banka)